These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27898072)

  • 1. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study.
    Rowland LM; Pradhan S; Korenic S; Wijtenburg SA; Hong LE; Edden RA; Barker PB
    Transl Psychiatry; 2016 Nov; 6(11):e967. PubMed ID: 27898072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders.
    Chiappelli J; Savransky A; Ma Y; Gao S; Kvarta MD; Kochunov P; Slavich GM; Hong LE
    Schizophr Res; 2024 Jul; 269():58-63. PubMed ID: 38733800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A
    Wijtenburg SA; Wright SN; Korenic SA; Gaston FE; Ndubuizu N; Chiappelli J; McMahon RP; Chen H; Savransky A; Du X; Wang DJ; Kochunov P; Hong LE; Rowland LM
    Neuropsychopharmacology; 2017 Jan; 42(2):562-571. PubMed ID: 27562377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study.
    Soeiro-de-Souza MG; Pastorello BF; Leite Cda C; Henning A; Moreno RA; Garcia Otaduy MC
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder.
    Ernst J; Hock A; Henning A; Seifritz E; Boeker H; Grimm S
    Mol Psychiatry; 2017 Jan; 22(1):113-119. PubMed ID: 27184123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG-Informed fMRI Reveals a Disturbed Gamma-Band-Specific Network in Subjects at High Risk for Psychosis.
    Leicht G; Vauth S; Polomac N; Andreou C; Rauh J; Mußmann M; Karow A; Mulert C
    Schizophr Bull; 2016 Jan; 42(1):239-49. PubMed ID: 26163477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
    Wood SJ; Yücel M; Wellard RM; Harrison BJ; Clarke K; Fornito A; Velakoulis D; Pantelis C
    Schizophr Res; 2007 Aug; 94(1-3):328-31. PubMed ID: 17574388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.
    Théberge J; Al-Semaan Y; Williamson PC; Menon RS; Neufeld RW; Rajakumar N; Schaefer B; Densmore M; Drost DJ
    Am J Psychiatry; 2003 Dec; 160(12):2231-3. PubMed ID: 14638596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Computerized test of Functional Capacity.
    Keefe RSE; Davis VG; Atkins AS; Vaughan A; Patterson T; Narasimhan M; Harvey PD
    Schizophr Res; 2016 Aug; 175(1-3):90-96. PubMed ID: 27091656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia.
    Kim SJ; Jung D; Shim JC; Moon JJ; Jeon DW; Kim YN; Seo YS; Jung SS; Seo BJ; Kim JE
    Asian J Psychiatr; 2019 Dec; 46():111-117. PubMed ID: 31654923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain lactate responses during visual stimulation in fasting and hyperglycemic subjects: a proton magnetic resonance spectroscopy study at 1.5 Tesla.
    Maddock RJ; Buonocore MH; Lavoie SP; Copeland LE; Kile SJ; Richards AL; Ryan JM
    Psychiatry Res; 2006 Nov; 148(1):47-54. PubMed ID: 17020804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.
    Dogan AE; Yuksel C; Du F; Chouinard VA; Öngür D
    Neuropsychopharmacology; 2018 Jul; 43(8):1681-1690. PubMed ID: 29581538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
    Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study.
    Rowland LM; Krause BW; Wijtenburg SA; McMahon RP; Chiappelli J; Nugent KL; Nisonger SJ; Korenic SA; Kochunov P; Hong LE
    Mol Psychiatry; 2016 Feb; 21(2):198-204. PubMed ID: 25824298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.